Mimedx (MDXG) Acquisitions (2011 - 2026)

Mimedx recorded quarterly Acquisitions of $5.0 million in Q1 2026, up 63.19% quarter-over-quarter from $3.1 million in Q3 2025.

Mimedx's Acquisitions history runs 5 years deep, the most recent figure standing at $5.0 million for Q1 2026.

In Q1 2026, Acquisitions changed N/A year-over-year to $5.0 million; the TTM figure through Mar 2026 stood at $8.8 million (up 206.22% YoY), while the FY2025 annual figure was $3.8 million, down 52.12% from the prior year.
Acquisitions came in at $5.0 million for Q1 2026 at Mimedx, up from $3.1 million in the prior quarter.
In the past five years, Acquisitions ranged from a high of $5.0 million in Q1 2024 to a low of $366000.0 in Q2 2024.
A 3-year average of $2.8 million and a median of $2.8 million in 2024 frame the typical range for Acquisitions.
On a YoY basis, Acquisitions climbed as much as 91.26% in 2025 and fell as far as 91.26% in 2025.
Mimedx's Acquisitions stood at $2.5 million in 2024, then rose by 22.76% to $3.1 million in 2025, then jumped by 63.19% to $5.0 million in 2026.
According to Business Quant data, Acquisitions over the past three periods registered $5.0 million, $3.1 million, and $700000.0 for Q1 2026, Q3 2025, and Q2 2025 respectively.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Quantum Biopharma	961,148.99 Bn	961,148.98 Bn	-	-
2	Alterity Therapeutics	744,933.29 Bn	744,933.26 Bn	-	-
3	Legend Biotech	2,540.00 Bn	2,539.71 Bn	242.10 Mn	-
4	Nanobiotix	2,199.85 Bn	2,199.78 Bn	-	-
5	Akari Therapeutics	1,635.88 Bn	1,635.88 Bn	-	-
6	Vertex Pharmaceuticals	111.32 Bn	104.07 Bn	2.59 Bn	-
7	Evaxion A	62.56 Bn	62.54 Bn	-	-
8	Regeneron Pharmaceuticals	62.55 Bn	53.79 Bn	3.31 Bn	-
9	Alnylam Pharmaceuticals	39.57 Bn	36.56 Bn	959.66 Mn	-
10	Mimedx	530.69 Mn	370.92 Mn	41.62 Mn	5.00 Mn

Download Data 🔒